Researcher profile
Cathrin Rohleder
Affiliations
Organizations
Public evidence
8 connected articles
Enhancing anandamide signalling through fatty acid amide hydrolase inhibition: An update on the pharmacological strategy for treating psychiatric disorders.2026 · Europe PMCDose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers.2024 · Europe PMCCannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state.2023 · Europe PMCPlasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density.2023 · Europe PMCSimultaneous Assessment of Serum Levels and Pharmacologic Effects of Cannabinoids on Endocannabinoids and <i>N</i>-Acylethanolamines by Liquid Chromatography-Tandem Mass Spectrometry.2023 · Europe PMCCannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial.2021 · Europe PMCEffects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers.2020 · Europe PMCCannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence.2016 · Europe PMC
Registered research
Connected studies
Combination of THC and CBD as Novel Treatment for Co-Occurring Opioid Use Disorder and Chronic Painnct06544291Evaluation of the Antipsychotic Efficacy of the Phytocannabinoid Cannabidiol in Treating Acute Schizophrenic Psychosis. A Double-Blind, Controlled Clinical Trialnct00628290Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids on the Endocannabinoid System, Cognition and Neuronal Oscillationsnct02487381
Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.